Course
Slides
Transcripts

The Immune System and Lysosomal Diseases

Lysosomal & Rare Disorders Research & Treatment Center

The Immune System and Lysosomal Diseases

December 31, 2022 – December 31, 2023

NO LONGER AVAILABLE FOR CREDIT

Estimated time to complete: 1.0 hours

Activity Description

This CME/CE activity highlights our current understanding of how the immune system plays a part in the pathophysiology and treatment of persons with lysosomal diseases.

Continuing Education Information

This continuing education activity is provided through collaboration between Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare, and AffinityCE. This activity provides continuing education credit for Physicians, Physician Assistants, Nurse Practitioners, Nurses, Genetic Counselors as well as a statement of participation for other participants.

Faculty

Ozlem Goker-Alpan, MD
Co-founder and President
Lysosomal & Rare Disorders Research & Treatment Center (LDRTC)

Oral Alpan, MD
Amerimmune
McLean, VA

Learning Outcomes

At the end of this activity, participants should be able to:

  • Describe how the immune system is involved in lysosomal disorders.
  • Review the pathophysiology of immune response reactions.
  • Describe how to better manage patients with immune response reactions.
  • Describe the best clinical practices to monitor the patients with immune response reactions.

Disclosures

AffinityCE, LDRTC, and CheckRare CE staff, as well as planning and review committees, have no financial interests to disclose and do not recommend the use of products outside of the FDA approved labelling.

Faculty Educators

Dr. Ozlem Goker-Alpan is a consultant, a principal investigator and /or on the speaker bureau, or has received grant support from the following pharmaceutical companies: Actelion, Amicus Therapeutics, Sanofi, Takeda, Pfizer/Protalix.

Dr. Oral Alpan is a consultant, a principal investigator and /or on the speaker bureau, or has received grant support from the following pharmaceutical companies: Sanofi.

Any conflict of interest for Drs. Goker-Alpan and Alpan were resolved through peer review of content by a non-conflicted reviewer.

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this enduring activity for a maximum of 1 hour of AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this enduring activity for a maximum of 1 hour of AMA PRA Category 1 Credit™. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Continuing Nursing Education is provided for this program through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). This activity provides a maximum of 1 hour of continuing nursing education credit.

Nurse Practitioners

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this enduring activity for a maximum of 1 hour of AMA PRA Category 1 Credit™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.

Genetic Counselors

Category 2 CEU

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this enduring activity for a maximum of 1 hour of AMA PRA Category 1 Credit™. This activity meets Category 2 CEUs requirements of the National Society of Genetic Counselors (NCGC).

Other Professionals

All other health care professionals completing this continuing education activity will be issued a Statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.

Commercial Support

Educational Support for this activity was provided by Takeda, Sanofi, and Chiesi.

Participation Costs

There is no cost to participate in these CE sessions.

CME Inquiries

For all CME policy-related inquiries, please contact us at ce@affinityced.com.
Send customer support requests to cds_support+ldrtc@affinityced.com.

The Immune System and Lysosomal Diseases

Slides

LDRTC2022 The Immune System and Lysosomal Diseases-slides Goker-Alpan

Dr Goker-Alpan's slides

 

LDRTC2022 The Immune System and Lysosomal Diseases-slides Alpan

Dr Alpan's slides

The Immune System and Lysosomal Diseases

Transcripts

Advances in Gene Therapy for Lysosomal Diseases-transcript